Allogene Therapeutics, Inc. (NASDAQ:ALLO) is one of the penny stocks with potential to rise 1000 percent. Allogene Therapeutics said on March 12, 2026, that its lead program, cemacabtagene ...
Synopsys (SNPS) is a buy: discounted valuation, pricing power, secular EDA growth, and Elliott catalyst. Read more macro analysis here.
Amazon's humanoid bet isn't about competing with Tesla's factory robots. Its about quietly building the operating system for ...
A beginner-friendly, AI-powered stock picking platform that helps you invest smarter—without the overwhelm—is on sale for $55.19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results